Category

News

TRHC’s CareKinesis Receives DEA Approval for Electronic Prescriptions for Controlled Substances (EPCS) for EireneRx

CareKinesis proprietary medication decision-support and e-prescribing platform, EireneRxCS, has been approved for the electronic prescribing of controlled substances as a result of receiving Drug Enforcement Administration (DEA) certification. Moorestown, NJ (November 23, 2015) — CareKinesis, Inc. Chief Information Officer, Joe Filippoli, MBA, announced today that the CareKinesis proprietary medication decision-support and e-prescribing platform, EireneRx, has been approved for the electronic prescribing of controlled substances as a result of receiving Drug Enforcement Administration (DEA) certification. InfoGard... Read More

CareKinesis CEO Named 2015 Health Care Innovator of the Year

Moorestown, NJ, October 16, 2015 – CareKinesis CEO, Calvin H. Knowlton, BSPharm, MDiv, PhD, has been named “Individual Health Care Innovator of the Year” by the Philadelphia Business Journal. The Award will be presented October 22 at the Crystal Tea Room in Philadelphia, PA. The purpose of the award is “to recognize those companies, products and individuals that are leading the pack in bringing break-through innovation in healthcare and the life sciences to the greater... Read More

Oak Street Health and Tabula Rasa Healthcare Aim to Improve Patient Outcomes Through Optimization of Medication Regimens

Moorestown, NJ, October 15, 2015 –(PR.com)– Oak Street Health, a Chicago-based network of primary care doctor’s offices specializing in the healthcare of older adults, and Tabula Rasa HealthCare, Inc., a leader in providing patient-specific, data-driven technology and solutions for health care organizations, announced a new pilot program to improve patient outcomes for Oak Street Health (OSH) patients. This new Medication Risk Mitigation™ (MRM) pilot will be launched in October at Oak Street Health’s Bronzeville Clinic... Read More

Immanuel Pathways PACE Chooses CareKinesis For its Pharmacy Services Partner

Moorestown, NJ, and Omaha, NE, October 15, 2015–Immanuel Pathways has chosen CareKinesis to provide medication management services to participants enrolled in its PACE Nebraska and PACE Iowa programs. As a Program of All-Inclusive Care for the Elderly (PACE) organization, Immanuel Pathways provides complete medical, health and social services from a centralized location as well as in participants’ homes, enabling seniors to live independently. “We are delighted to serve Immanuel Pathways as its partner in medication... Read More

EmblemHealth and Tabula Rasa HealthCare Announce New Medication Therapy Management Program

from businesswire EmblemHealth, New York’s leading health benefits and wellness company, and Tabula Rasa HealthCare, a family of companies devoted to leveraging technology to improve healthcare, announced the launch of a new Medication Therapy Management (MTM) pilot program. Medicare’s Part D Medication Therapy Management Program (MTMP) requires Part D sponsors, such as EmblemHealth, to ensure optimal therapeutic outcomes for targeted beneficiaries through improved medication use. The pilot program, entitled MTM+, or MTM Plus, is a proof... Read More

Tabula Rasa HealthCare Names Chief Scientific Officer: Jacques Turgeon, BPharm, PhD

MOORESTOWN, N.J.–(BUSINESS WIRE)–Tabula Rasa HealthCare, Inc. Chairman and Chief Executive Officer, Calvin H. Knowlton, BSc Pharm, MDiv, PhD, announced today the appointment of Jacques Turgeon, B.Pharm., Ph.D., to the company’s newly created position of Chief Scientific Officer. Tabula Rasa HealthCare offers medication risk mitigation and risk adjustment services for at-risk health plans, health systems, hospitals, skilled rehabilitation, long-term care, and other healthcare entities. “We believe that by limiting drug-drug interaction, healthcare providers and patients will... Read More

Kevin T. Bain Elected to CCGP Board of Commissioners

from ccgp.org The Board of Commissioners of the Commission for Certification in Geriatric Pharmacy has chosen Kevin T. Bain of Delanco, New Jersey to fill a vacancy on the Board resulting from a resignation by a Board member. Dr. Bain is Vice President, Medication Risk Mitigation for Tabula Rasa HealthCare.  In that role, he oversees the company’s proprietary Medication Risk Mitigation (MRM) platform and leads applied pharmacogenomics to personalize and optimize the selection and use... Read More

Dr. Calvin Knowlton receives Emerald Asset Management E-3 Award

from BusinessWire LEOLA, Pa.–(BUSINESS WIRE)–The chief executive officers of Alnylam Pharmaceuticals (NASDAQ: ALNY), Apogee Enterprises (NASDAQ: APOG), Proofpoint, Inc. (NASDAQ: PFPT) and CareKinesis (privately held) have been named as the recipients of the fifteenth annual “E-3 Awards,” presented by Emerald Asset Management at the 22nd Annual Emerald Groundhog Day Investment Forum, held in Philadelphia on February 5, 2015. Joseph Besecker, President of Emerald Asset Management said, “We created this unique award to recognize leaders who... Read More

Calvin H. Knowlton Receives Remington Honor Medal, Highest Honor in Pharmacy

from APHA WASHINGTON, DC – Calvin H. Knowlton, BSPharm, MDiv, PhD, of Moorestown, NJ, is the recipient of the 2015 Remington Honor Medal, the highest honor bestowed by the American Pharmacists Association (APhA). Knowlton was selected in recognition of the professional achievements, innovations and advancements he has contributed to the pharmacy profession. Knowlton is currently the founder and CEO of Tabula Rasa HealthCare, Inc., the parent company of CareKinesis, Inc., the tenth company founded in... Read More